Serial Number
86282220
Owner
CTI BIOPHARMA CORP.Attorney
Frances M. JaglaFirst Use Date
Dec 18, 2015
Filing Date
May 15, 2014
CTI BIOPHARMA Trademark
Serial Number: 86282220 • Registration: 5166752
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
Frances M. Jagla CHRISTENSEN O'CONNOR JOHNSON KINDNESS PLLC
1201 Third Avenue, Suite 3600
Seattle, WA 98101
UNITED STATES
Trademark Details
Filing Date
May 15, 2014
Registration Date
March 21, 2017
First Use Anywhere
December 18, 2015
First Use in Commerce
December 18, 2015
Published for Opposition
December 15, 2015
Goods & Services
Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders
Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing
Pharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens
